SearcharxivSearch

arXiv subjects

En Xie

Publications and source records attributed to En Xie.

2 recordsLinked to original sources

Systematic Literature Reviews With Two Multi-Agentic Systems And Human-In-The-Loop

Systematic literature review of clinical trials drives regulatory decision-making, but conventional screening and extraction are time-consuming, labor-intensive, and vulnerable to study selection bias. We propose two fit-to-purpose multi-agentic systems (MAS) for systematic literature review, with human-in-the-loop. The screening MAS uses multiple LLM agents with heterogeneous personas and multiround cross-review, and uniformly improves accuracy over a single-LLM baseline. The extraction MAS combines standardization, an iterative correction loop, and retrieval-based context control to ensure accuracy and scalability. Both MAS are specifically designed to support Human-In-The-Loop which is essential for clinical decisions. The novelty of the proposed approach lies in the system architecture rather than in any single foundation tools: the system can naturally benefit from future improvements in the underlying tools, for instance, stronger LLM agents, retrieval engines, image recognition methods, etc. As a real-world application, a published network meta-analysis is reproduced by the MAS. The result recovers all trials from the original study and identifies additional eligible trials missed by manual review, leading to updated clinical conclusions.

stat.AP

SynthIPD: training-free synthetic individual patient data generation

Individual patient data (IPD) are essential for statistical inference in clinical research. However, privacy concerns, high data-sharing costs, and restrictive access often make IPD unavailable. Conventional synthetic data generation usually relies on black box models such as generative adversial networks. These methods, however, requires a large piece of IPD for model training, may be ungeneralizable and lacks interpretability. This paper introduces an assumption-lean, three-step methodology for generating synthetic IPD with survival endpoints only based on published clinical trial articles. The method mainly leverages Kaplan-Meier (KM) curves with at-risk/censoring information and subgroup-level summary statistics. It digitizes the KM curve using Scalable Vector Graphics (SVG) beyond pixel accuracy and then generates synthetic covariates based on the statistics. We illustrate the method's potential through $2$ detailed case studies and simulation studies. The method offers important implications, enabling high-fidelity IPD generation to support evidence-based medical decisions.

stat.AP